Intech is focusing on the development and manufacturing of new combination, new formulation and generic drugs with high barrier for the treatment of respiratory diseases. With the unique technology, it is moving forward to international market.
Intech owns patented MDI platform iLEF (Inhaled Low Ethanol Formulation ) with many advantages. The particle size of drug ingredients is well controlled and delivered to the suitable tissue of human body to treat asthma and COPD.
Intech owns the capability of DPI development and manufacturing. With the lling technology of blisters and capsules, these products combined with device are convenient to use and safe. More than that, the patented designed Pandahaler is popular and attractive.